<em>Clostridioides difficile</em> infection: painting a picture of prediction and prevention
12 July 2021
8. Healthcare-associated & nosocomial infections, infection control, 1,5-hour Oral Session
•
S127
•
13:15
>
14:45
•
Clostridioides difficile infection: painting a picture of prediction and prevention
•
8. Infection prevention & control
13:15
•
4517
•
Opioid treatment and outcomes of <em>Clostridioides difficile</em> infection
>
N.
Noy
MESHULAMI (New York)
13:25
•
2962
•
A pan-European cost-of-illness analysis of patients with <em>Clostridioides difficile</em> infection: results of COMBACTE-CDI
>
S.
Sebastian
WINGEN-HEIMANN (Cologne)
13:35
•
3238
•
Impact of testing on <em>Clostridioides Difficile</em> infection in hospitals across Europe: a mathematical model
>
E.
Emily
AGNEW (London)
13:45
•
3793
•
A national ISO:15189 accredited <em>Clostridioides difficile</em> whole genome sequencing single-nucleotide polymorphism typing service in Wales
>
M.
Michael
PERRY (Cardiff)
13:55
•
4405
•
Differentiation of the microbiome of patients with <em>Clostridioides difficile</em> infection, patients with non<em>-C. difficile</em> diarrhoea and <em>C. difficile</em> colonised patients
>
S.
Silvia Noemi
VÁZQUEZ-CUESTA (Madrid)
14:05
•
2559
•
Faecal microbiota transplantation does not eradicate<em> Clostridioides difficile</em> in patients with multiple recurrent infections, despite clinical efficacy
>
E.
Elisabeth
TERVEER (Leiden)
14:15
•
3646
•
Development of a defined bacterial consortium for the prevention of recurrent <em>Clostridioides difficile</em> infection
>
R.
Rajita
MENON (Brighton)
14:25
•
INT90
•
Q&A/Discussion
|